Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Spinal cord stimulation (SCS) is available to patients at Weill Cornell Medicine, as part of the individualized and multidisciplinary approach to pain treatment at the Division of Pain Management.
SCS is a type of neuromodulation. This system works by applying small electrical impulses to the spinal cord to alleviate pain. It is used most often to treat complex or unmanageable back pain and neuropathy.
Neuromodulation is a technique to treat pain by directly stimulating the nervous system with electrical signals. The neuromodulation team at Weill Cornell includes specialized physicians and researchers from the Pain Management and Neurosurgery departments. It is one of the largest and busiest in New York City.
We perform spinal cord stimulation to treat:
Weill Cornell Medicine Division of Pain Management was one of the first hospitals to adopt and offer the Nevro Senza SCS system HF10 Therapy, which was approved by the FDA in May 2015. The Senza SCS system uses electrical impulses to alleviate:
Currently, this therapy is the only SCS system with FDA approval to:
Our expert pain management physicians offer the advanced Nevro Senza HF10 Therapy, building on their extensive experience with other spinal cord stimulation treatments for relieving chronic pain.
Nevro Senza HF10, other SCS systems, and all the treatments we offer are part of our multidisciplinary approach to pain management. They are important tools for designing individualized treatment and pain management programs we design to help each of our patients.
Since we promote an individualized approach to pain management, SCS and the HF10 therapy may or may not be the right option for you. If you would like to find out more, please contact us today to make an appointment.
Learn more about the conditions we treat and the services we offer.